In a report released today, Eric Sheridan from Goldman Sachs maintained a Hold rating on Snap, with a price target of $9.00. The company’s shares opened today at $7.50. Elevate ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

By Nell Mackenzie LONDON (Reuters) -Big investors are turning more cautious on areas such as passive equities and private ...

As a college student, Goldman partner Jennifer Roth thought Wall Street was out of reach. Then she had an unexpected ...

Goldman Sachs BDC, Inc. ("GSBD", the "Company", "we", "us", or "our") (NYSE: GSBD) today reported financial results for the second quarter ended June 30, 2025 and filed its Form 10-Q with the U.S.

Goldman Sachs BDC Inc. GSBD) on Thursday reported second-quarter profit of $39.3 million. On a per-share basis, the New York-based company said it had net income of 34 cents.

We had previously estimated a potential direct impact of around 0.3 percentage point (annualized) to India's real GDP growth, ...

Goldman Sachs downgraded Glencore (LON: GLEN) shares to Neutral from Buy, flagging a challenging free cash flow (FCF) outlook ...

Goldman Sachs BDC (GSBD) came out with quarterly earnings of $0.38 per share, missing the Zacks Consensus Estimate of $0.4 per share. This compares to earnings of $0.57 per share a year ago. These ...

Goldman Sachs raised its price target on Nvidia to $200 per share, up from $185, in a Thursday note ahead of the company’s ...

Goldman, which has been in Chicago for more than 100 years, is trying to boost its presence in the city beyond just the ...

Goldman Sachs raises Nvidia’s price target to $200 ahead of Q2 earnings, citing confidence in AI chip demand and China ...